Health CanadaGeneral Alert

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Name: For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and yo...
Brand: Marketed health products
SKU: CANADA-24475
Availability: Discontinued
Rating: 1.0 (1 reviews)

Published: July 27, 2006Recall ID: 24475Category: generalCountry: Canada

Safety AlertHealth Canada Canada

Canada

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Recalling Firm: Marketed health products

Product Description & Identification

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Additional Source Details

Field	Value
N I D	24475
U R L	https://recalls-rappels.canada.ca/en/alert-recall/public-possible-association-remicade-infliximab-hepatosplenic-t-cell-lymphoma
Title	For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease
Archived	1
Category	Biologic or vaccine
Last updated	2006-07-27
Organization	Marketed health products

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode Scanner VIN Vehicle Check Pantry Safety Audit

Overview

Recalling FirmMarketed health products

Recall Hazard Severity

Caution (Class III)

Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Marketed health products - For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Check if your household is affected:
https://therecallfile.com/recalls/for-the-public-possible-association-of-remicade-infliximab-with-hepato/CANADA-24475

WhatsApp Facebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Spread the WordFor the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Install The Recall File App

Notification

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

For the Public - Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease

Product Description & Identification

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Related Recalls

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018409 -

Transport Canada Recall - 2018409 -

Install The Recall File App

Notification